J
James J. DiNicolantonio
Researcher at University of Missouri–Kansas City
Publications - 224
Citations - 6928
James J. DiNicolantonio is an academic researcher from University of Missouri–Kansas City. The author has contributed to research in topics: Clopidogrel & Acute coronary syndrome. The author has an hindex of 41, co-authored 215 publications receiving 5425 citations. Previous affiliations of James J. DiNicolantonio include Ithaca College & Mount Sinai St. Luke's and Mount Sinai Roosevelt.
Papers
More filters
Journal ArticleDOI
Alcohol and cardiovascular health: the dose makes the poison…or the remedy.
TL;DR: Of the various drinking patterns, daily low- to moderate-dose alcohol intake, ideally red wine before or during the evening meal, is associated with the strongest reduction in adverse cardiovascular outcomes.
Journal ArticleDOI
Effects of Habitual Coffee Consumption on Cardiometabolic Disease, Cardiovascular Health, and All-Cause Mortality
James H. O'Keefe,Salman K. Bhatti,Harshal Patil,James J. DiNicolantonio,Sean C. Lucan,Carl J. Lavie +5 more
TL;DR: A daily intake of ∼2 to 3 cups of coffee appears to be safe and is associated with neutral to beneficial effects for most of the studied health outcomes, however, most ofThe data on coffee's health effects are based on observational data, with very few randomized, controlled studies, and association does not prove causation.
Journal ArticleDOI
The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease
TL;DR: To reduce the burden of CHD, guidelines should focus particularly on reducing intake of concentrated sugars, specifically the fructose-containing sugars like sucrose and high-fructose corn syrup in the form of ultra-processed foods and beverages.
Journal ArticleDOI
Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
Sripal Bangalore,Harikrishna Makani,Martha J. Radford,Kamia Thakur,Bora Toklu,Stuart D. Katz,James J. DiNicolantonio,James J. DiNicolantonio,Philip J. Devereaux,Karen P. Alexander,Jørn Wetterslev,Franz H. Messerli +11 more
TL;DR: In this article, the authors conducted a MEDLINE/EMBASE/CENTRAL search for randomized trials evaluating β-blockers in myocardial infarction enrolling at least 100 patients.
Journal ArticleDOI
Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.
TL;DR: Subclinical magnesium deficiency increases the risk of numerous types of cardiovascular disease, costs nations around the world an incalculable amount of healthcare costs and suffering, and should be considered a public health crisis.